0001209191-22-046598.txt : 20220818
0001209191-22-046598.hdr.sgml : 20220818
20220818160727
ACCESSION NUMBER: 0001209191-22-046598
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220816
FILED AS OF DATE: 20220818
DATE AS OF CHANGE: 20220818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brandt Peter C.
CENTRAL INDEX KEY: 0001434099
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39692
FILM NUMBER: 221177569
MAIL ADDRESS:
STREET 1: NOVEN PHARMACEUTICALS, INC.
STREET 2: 11960 SW 144TH STREET
CITY: MIAMI
STATE: FL
ZIP: 33186
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IN8BIO, INC.
CENTRAL INDEX KEY: 0001740279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 825462585
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: EMPIRE STATE BUILDING
STREET 2: 350 5TH AVENUE, SUITE 5330
CITY: NEW YORK
STATE: NY
ZIP: 10118
BUSINESS PHONE: (646) 600-6438
MAIL ADDRESS:
STREET 1: EMPIRE STATE BUILDING
STREET 2: 350 5TH AVENUE, SUITE 5330
CITY: NEW YORK
STATE: NY
ZIP: 10118
FORMER COMPANY:
FORMER CONFORMED NAME: Incysus Therapeutics, Inc.
DATE OF NAME CHANGE: 20180510
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-16
0
0001740279
IN8BIO, INC.
INAB
0001434099
Brandt Peter C.
C/O IN8BIO, INC.
350 5TH AVE. SUITE 5330
NEW YORK
NY
10118
1
0
0
0
Common Stock
2022-08-16
4
P
0
105263
1.90
A
182473
D
Common Stock
105290
I
See footnote
Includes 77,210 shares received as an annual annuity payment from the Reporting Person's GRAT. This transfer constitutes a mere change in the form of ownership and is exempt from reporting pursuant to Rule 16a-13.
The securities are held by The Peter C. Brandt 2020-4 GRAT (the "GRAT"). The Reporting Person is the trustee of the GRAT and, as such, has voting and investment power over the shares held by the GRAT.
/s/ Jason Minio, Attorney-in-Fact
2022-08-18